Curex promoted these as same as Ozempic / Mounjaro, which the FDA declared misbranding, since these compounded formulations are not FDA-approved
20, 2025 from Transportation Security Administration (TSA-a)
The FDA approval of Wegovy pill is based on the results from the OASIS 4 Phase 3 clinical trial, which was a 64-week medical study that included 307 adults with obesity or overweight with one or more weight-related comorbidities, without diabetes
Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R
A 2025 narrative review in Clinical Therapeutics found that across 19 real-world studies, oral semaglutide delivered a median HbA1c reduction of around 1% and a median body weight reduction of 2 to 3 kg at six months, while showing a safety profile that was broadly in line with clinical trials (source)